Ausgabe 4/2010
Inhalt (5 Artikel)
The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?
Kerensa Broersen, Frederic Rousseau, Joost Schymkowitz
Advances in quantitative magnetic resonance imaging-based biomarkers for Alzheimer disease
Bradford C Dickerson
The role of animal models in advancing amyloid-beta immunotherapy to the clinic
Dora Games, Peter Seubert
Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?
Philippe Robert, Steven Ferris, Serge Gauthier, Ralf Ihl, Bengt Winblad, Frank Tennigkeit